Pharmesis International Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Xuedan Wu
Chief executive officer
CN¥715.0k
Total compensation
| CEO salary percentage | 100.00% |
| CEO tenure | 7.4yrs |
| CEO ownership | n/a |
| Management average tenure | 4.2yrs |
| Board average tenure | 10.5yrs |
Recent management updates
Recent updates
Impressive Earnings May Not Tell The Whole Story For Pharmesis International (SGX:BFK)
Mar 07
Pharmesis International (SGX:BFK) Takes On Some Risk With Its Use Of Debt
Mar 03Is Pharmesis International (SGX:BFK) Using Too Much Debt?
Oct 10Would Pharmesis International (SGX:BFK) Be Better Off With Less Debt?
Dec 09Health Check: How Prudently Does Pharmesis International (SGX:BFK) Use Debt?
Jun 08A Look At The Intrinsic Value Of Pharmesis International Ltd. (SGX:BFK)
Feb 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | CN¥715k | CN¥715k | CN¥8m |
Compensation vs Market: Xuedan's total compensation ($USD99.20K) is below average for companies of similar size in the SG market ($USD390.30K).
Compensation vs Earnings: Insufficient data to compare Xuedan's compensation with company performance.
CEO
Xuedan Wu (61 yo)
7.4yrs
Tenure
CN¥715,000
Compensation
Mr. Xuedan Wu has been an Executive Director of Pharmesis International Ltd. since April 16, 2004 and has been its Chief Executive Officer since December 31, 2017. Mr. Wu served as the Chief Executive Offi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 7.4yrs | CN¥715.00k | no data | |
| Financial Controller | 8.9yrs | no data | no data | |
| Joint Company Secretary | less than a year | no data | no data | |
| Joint Company Secretary | less than a year | no data | no data |
4.2yrs
Average Tenure
Experienced Management: BFK's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 21.1yrs | CN¥715.00k | no data | |
| Non-Independent Non-Executive Chairman | 19.5yrs | CN¥240.50k | no data | |
| Lead Independent Director | 1.6yrs | CN¥213.78k | no data | |
| Independent Non-Executive Director | 1yr | CN¥8.00k | no data |
10.5yrs
Average Tenure
61yo
Average Age
Experienced Board: BFK's board of directors are seasoned and experienced ( 10.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/14 10:46 |
| End of Day Share Price | 2025/05/13 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pharmesis International Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.